View in EDS PDF Full Text

Cancer stem cell-immune cell crosstalk in the tumor microenvironment for liver cancer progression.

Saved in:
Bibliographic Details
Title: Cancer stem cell-immune cell crosstalk in the tumor microenvironment for liver cancer progression.
Authors: Ma Y; Cancer Research Center, First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230027, China.; National Center for Liver Cancer, Naval Medical University (Second Military Medical University), Shanghai, 201805, China., Lv H; Cancer Research Center, First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230027, China.; National Center for Liver Cancer, Naval Medical University (Second Military Medical University), Shanghai, 201805, China.; International Co-operation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Naval Medical University (Second Military Medical University), Shanghai, 200438, China., Xing F; Cancer Research Center, First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230027, China.; National Center for Liver Cancer, Naval Medical University (Second Military Medical University), Shanghai, 201805, China., Xiang W; Cancer Research Center, First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230027, China.; National Center for Liver Cancer, Naval Medical University (Second Military Medical University), Shanghai, 201805, China., Wu Z; Cancer Research Center, First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230027, China.; National Center for Liver Cancer, Naval Medical University (Second Military Medical University), Shanghai, 201805, China., Feng Q; Cancer Research Center, First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230027, China.; National Center for Liver Cancer, Naval Medical University (Second Military Medical University), Shanghai, 201805, China., Wang H; Cancer Research Center, First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230027, China. hywangk@vip.sina.com.; National Center for Liver Cancer, Naval Medical University (Second Military Medical University), Shanghai, 201805, China. hywangk@vip.sina.com.; International Co-operation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Naval Medical University (Second Military Medical University), Shanghai, 200438, China. hywangk@vip.sina.com.; Shanghai Key Laboratory of Hepato-biliary Tumor Biology, Shanghai, 200438, China. hywangk@vip.sina.com.; Key Laboratory of Signaling Regulation and Targeting Therapy of Liver Cancer, Ministry of Education, Shanghai, 200438, China. hywangk@vip.sina.com., Yang W; Cancer Research Center, First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230027, China. woodeasy66@hotmail.com.; National Center for Liver Cancer, Naval Medical University (Second Military Medical University), Shanghai, 201805, China. woodeasy66@hotmail.com.; International Co-operation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Naval Medical University (Second Military Medical University), Shanghai, 200438, China. woodeasy66@hotmail.com.; Shanghai Key Laboratory of Hepato-biliary Tumor Biology, Shanghai, 200438, China. woodeasy66@hotmail.com.; Key Laboratory of Signaling Regulation and Targeting Therapy of Liver Cancer, Ministry of Education, Shanghai, 200438, China. woodeasy66@hotmail.com.
Source: Frontiers of medicine [Front Med] 2024 Jun; Vol. 18 (3), pp. 430-445. Date of Electronic Publication: 2024 Apr 11.
Publication Type: Journal Article; Review
Journal Info: Publisher: Higher Education Press Country of Publication: China NLM ID: 101549428 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2095-0225 (Electronic) Linking ISSN: 20950217 NLM ISO Abbreviation: Front Med Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38600350
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cancer stem cell-immune cell crosstalk in the tumor microenvironment for liver cancer progression.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ma+Y%22">Ma Y</searchLink>; Cancer Research Center, First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230027, China.; National Center for Liver Cancer, Naval Medical University (Second Military Medical University), Shanghai, 201805, China.<br /><searchLink fieldCode="AU" term="%22Lv+H%22">Lv H</searchLink>; Cancer Research Center, First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230027, China.; National Center for Liver Cancer, Naval Medical University (Second Military Medical University), Shanghai, 201805, China.; International Co-operation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Naval Medical University (Second Military Medical University), Shanghai, 200438, China.<br /><searchLink fieldCode="AU" term="%22Xing+F%22">Xing F</searchLink>; Cancer Research Center, First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230027, China.; National Center for Liver Cancer, Naval Medical University (Second Military Medical University), Shanghai, 201805, China.<br /><searchLink fieldCode="AU" term="%22Xiang+W%22">Xiang W</searchLink>; Cancer Research Center, First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230027, China.; National Center for Liver Cancer, Naval Medical University (Second Military Medical University), Shanghai, 201805, China.<br /><searchLink fieldCode="AU" term="%22Wu+Z%22">Wu Z</searchLink>; Cancer Research Center, First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230027, China.; National Center for Liver Cancer, Naval Medical University (Second Military Medical University), Shanghai, 201805, China.<br /><searchLink fieldCode="AU" term="%22Feng+Q%22">Feng Q</searchLink>; Cancer Research Center, First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230027, China.; National Center for Liver Cancer, Naval Medical University (Second Military Medical University), Shanghai, 201805, China.<br /><searchLink fieldCode="AU" term="%22Wang+H%22">Wang H</searchLink>; Cancer Research Center, First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230027, China. hywangk@vip.sina.com.; National Center for Liver Cancer, Naval Medical University (Second Military Medical University), Shanghai, 201805, China. hywangk@vip.sina.com.; International Co-operation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Naval Medical University (Second Military Medical University), Shanghai, 200438, China. hywangk@vip.sina.com.; Shanghai Key Laboratory of Hepato-biliary Tumor Biology, Shanghai, 200438, China. hywangk@vip.sina.com.; Key Laboratory of Signaling Regulation and Targeting Therapy of Liver Cancer, Ministry of Education, Shanghai, 200438, China. hywangk@vip.sina.com.<br /><searchLink fieldCode="AU" term="%22Yang+W%22">Yang W</searchLink>; Cancer Research Center, First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230027, China. woodeasy66@hotmail.com.; National Center for Liver Cancer, Naval Medical University (Second Military Medical University), Shanghai, 201805, China. woodeasy66@hotmail.com.; International Co-operation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Naval Medical University (Second Military Medical University), Shanghai, 200438, China. woodeasy66@hotmail.com.; Shanghai Key Laboratory of Hepato-biliary Tumor Biology, Shanghai, 200438, China. woodeasy66@hotmail.com.; Key Laboratory of Signaling Regulation and Targeting Therapy of Liver Cancer, Ministry of Education, Shanghai, 200438, China. woodeasy66@hotmail.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101549428%22">Frontiers of medicine</searchLink> [Front Med] 2024 Jun; Vol. 18 (3), pp. 430-445. <i>Date of Electronic Publication: </i>2024 Apr 11.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Higher+Education+Press%22">Higher Education Press </searchLink><i>Country of Publication: </i>China <i>NLM ID: </i>101549428 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2095-0225 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220950217%22">20950217 </searchLink><i>NLM ISO Abbreviation: </i>Front Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38600350
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s11684-023-1049-z
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 430
    Titles:
      – TitleFull: Cancer stem cell-immune cell crosstalk in the tumor microenvironment for liver cancer progression.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ma Y
      – PersonEntity:
          Name:
            NameFull: Lv H
      – PersonEntity:
          Name:
            NameFull: Xing F
      – PersonEntity:
          Name:
            NameFull: Xiang W
      – PersonEntity:
          Name:
            NameFull: Wu Z
      – PersonEntity:
          Name:
            NameFull: Feng Q
      – PersonEntity:
          Name:
            NameFull: Wang H
      – PersonEntity:
          Name:
            NameFull: Yang W
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2024 Jun
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2095-0225
          Numbering:
            – Type: volume
              Value: 18
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Frontiers of medicine
              Type: main
ResultId 1